TokenPost·
Zai Lab Agrees to $250 Million ADS Placement for Drug Development

$250M
ADS placement
The Nasdaq-listed drugmaker expects $241.17 million after expenses, primarily to fund global development of zocilurtatug pelitecan.
Every crypto headline. One feed. Updated every minute.

The Nasdaq-listed drugmaker expects $241.17 million after expenses, primarily to fund global development of zocilurtatug pelitecan.